Jpmorgan Chase & Co »

Reneo Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $26k 16k 1.60
2023-09-30 $65k 8.6k 7.62
2023-06-30 $51k 7.7k 6.56
2023-03-31 $118k 20k 5.97
2022-12-31 $45k 20k 2.31
2022-03-31 $12k 4.1k 2.94
2021-12-31 $21k 2.4k 8.67